These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15791565)

  • 41. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.
    Ding Q; Xia W; Liu JC; Yang JY; Lee DF; Xia J; Bartholomeusz G; Li Y; Pan Y; Li Z; Bargou RC; Qin J; Lai CC; Tsai FJ; Tsai CH; Hung MC
    Mol Cell; 2005 Jul; 19(2):159-70. PubMed ID: 16039586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wnt/beta-catenin signaling in development and disease.
    Clevers H
    Cell; 2006 Nov; 127(3):469-80. PubMed ID: 17081971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.
    Cho M; Gwak J; Park S; Won J; Kim DE; Yea SS; Cha IJ; Kim TK; Shin JG; Oh S
    FEBS Lett; 2005 Aug; 579(20):4213-8. PubMed ID: 16051228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma.
    Zhang WM; Lo Muzio L; Rubini C; Yan G
    Oncol Rep; 2005 Jun; 13(6):1095-9. PubMed ID: 15870927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mesoderm induction and neural induction].
    Ueno N
    Tanpakushitsu Kakusan Koso; 2005 May; 50(6 Suppl):583-7. PubMed ID: 15926484
    [No Abstract]   [Full Text] [Related]  

  • 46. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
    Kim Y; Sills RC; Houle CD
    Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wnt signaling through canonical and non-canonical pathways: recent progress.
    Widelitz R
    Growth Factors; 2005 Jun; 23(2):111-6. PubMed ID: 16019432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic alterations in hepatocellular adenomas.
    Bioulac-Sage P; Laurent-Puig P; Balabaud C; Zucman-Rossi J
    Hepatology; 2003 Feb; 37(2):480; author reply 480-1. PubMed ID: 12540806
    [No Abstract]   [Full Text] [Related]  

  • 50. Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype.
    Kowara R; Karaczyn A; Cheng RY; Salnikow K; Kasprzak KS
    Toxicol Appl Pharmacol; 2005 May; 205(1):1-10. PubMed ID: 15885260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Up-regulation of beta-catenin in external auditory canal cholesteatoma.
    Naim R; Chang RC; Anders C; Sadick H; Riedel F; Bayerl C; Bran G; Hormann K
    Int J Mol Med; 2005 May; 15(5):801-4. PubMed ID: 15806301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic selection for modulators of the MAP kinase and beta-catenin growth-control pathways in mammalian cells.
    Wheatley W; Yoo S; Pierce M; Rebentisch M; Endo M; Peterson I; Stump M; McCormack K; Garcia-Guzman M; Kamb A
    Biochem Genet; 2002 Dec; 40(11-12):359-78. PubMed ID: 12463345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the human beta-catenin gene.
    Norris AL; Bailey A; Askham J; Whitehouse A; Clissold PM; Markham AF; Meredith DM
    Mamm Genome; 1996 Feb; 7(2):160-2. PubMed ID: 8835538
    [No Abstract]   [Full Text] [Related]  

  • 55. Improved blunt-end cloning by replacing EcoRV with Eco32I.
    Koesters R; von Knebel Doeberitz M
    Biotechniques; 2002 Jun; 32(6):1244, 1246. PubMed ID: 12074151
    [No Abstract]   [Full Text] [Related]  

  • 56. Association between the expression of epithelial-mesenchymal transition (EMT)-related markers and oncologic outcomes of colorectal cancer.
    Emile MH; Emile SH; El-Karef AA; Ebrahim MA; Mohammed IE; Ibrahim DA
    Updates Surg; 2024 May; ():. PubMed ID: 38762631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies.
    Goncharov AP; Vashakidze N; Kharaishvili G
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer.
    Ku SC; Liu HL; Su CY; Yeh IJ; Yen MC; Anuraga G; Ta HDK; Chiao CC; Xuan DTM; Prayugo FB; Wang WJ; Wang CY
    Aging (Albany NY); 2022 Oct; 14(20):8498-8567. PubMed ID: 36315446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epithelial-Mesenchymal Transition in Cancer: A Historical Overview.
    Ribatti D; Tamma R; Annese T
    Transl Oncol; 2020 Jun; 13(6):100773. PubMed ID: 32334405
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LKB1 and YAP phosphorylation play important roles in Celastrol-induced β-catenin degradation in colorectal cancer.
    Wang S; Ma K; Zhou C; Wang Y; Hu G; Chen L; Li Z; Hu C; Xu Q; Zhu H; Liu M; Xu N
    Ther Adv Med Oncol; 2019; 11():1758835919843736. PubMed ID: 31040884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.